Participants are taking commemorative photos at the ceremony to commemorate the new listing on the stock market of SK Biopharm held at the Korea Exchange in Yeouido, Seoul on the 2nd. On this day, SK Biopharm opened at 98,000 won, twice the public offering price (49,000 won), and went directly to the upper limit (127,000 won). /Provided by Korea Exchange
SK Biopharmaceutical stocks are expected to be released to the market from the first trading day of the new year. This is the quantity at which institutional investors’ mandatory holding period ends. As the largest amount of mandatory holdings has been released since listing, investors are increasingly interested in future share price movements.
According to the Korea Exchange on the 4th, 49,202,063 shares of SK Biopharm stocks held by institutional investors will be released to the market from this day after the six-month mandatory holding period. This is more than 37% of the 13.2 million shares allocated by institutions at the time of the public offering of SK Biopharm.
Of the 13.2 million stocks, 631 million were put on the market at the same time as the listing, and the remaining 6.9 million shares were subject to a mandatory retention period from 15 days to 6 months from the date of listing. Instead of receiving a lot of public offering stocks, institutional investors decided to hold public offering stocks for a certain period after listing.
This is the last stock with a mandatory holding period. 15 days after the listing, 137,000 shares, 262,500 shares a month later, and 1.7 million shares in October were on the market.
Compared to the volume released so far, this volume is far superior and is expected to shock the stock price in the short term. The average trading volume of SK Biopharm on the last 5 trading days was about 173,000 shares, and the stocks on the market this time are about 30 times the average trading volume.
SK Biopharm’s share price still exceeds the public offering price of 49,000 won. On the last trading day of last year, SK Biopharm finished the deal for 169,000 won. This is a return of 244% compared to the offering price.
Reporter Lee Song-ryul [email protected]
Ⓒ Hankyung.com prohibits unauthorized reproduction and redistribution